|
1
|
Kremastiotis G, Efentakis P, Varela A, Davos CH, Papanagnou ED, Trougakos IP, Kastritis E, Kanaki Z, Iliodromitis EK, Klinakis A, Dimopoulos MA, Terpos E, Andreadou I. P4787Investigating the molecular mechanisms of carfilzomib-induced cardiotoxicity and the emerging role of metformin as a prophylactic therapy. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- G Kremastiotis
- School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - P Efentakis
- School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - A Varela
- Biomedical Research Foundation Academy of Athens, Athens, Greece
| | - C H Davos
- Biomedical Research Foundation Academy of Athens, Athens, Greece
| | - E.-D Papanagnou
- Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - I P Trougakos
- Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - E Kastritis
- Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Z Kanaki
- Biomedical Research Foundation Academy of Athens, Athens, Greece
| | - E K Iliodromitis
- 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - A Klinakis
- Biomedical Research Foundation Academy of Athens, Athens, Greece
| | - M A Dimopoulos
- Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - E Terpos
- Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - I Andreadou
- School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
|
2
|
Kremastiotis G, Efentakis P, Varela A, Davos C, Tsoumani M, Papanagnou E, Trougakos I, Kastritis E, Kanaki Z, Iliodromitis E, Klinakis A, Dimopoulos M, Terpos E, Andreadou I. The proteasome inhibitor carfilzomib (Cfz) induces cardiotoxicity in vivo: molecular mechanisms and the cardioprotective effect of metformin (Met). J Mol Cell Cardiol 2018. [DOI: 10.1016/j.yjmcc.2018.05.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|